Does INFLIXIMAB Cause Basal cell carcinoma? 1,340 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,340 reports of Basal cell carcinoma have been filed in association with INFLIXIMAB (Renflexis). This represents 1.0% of all adverse event reports for INFLIXIMAB.
1,340
Reports of Basal cell carcinoma with INFLIXIMAB
1.0%
of all INFLIXIMAB reports
11
Deaths
652
Hospitalizations
How Dangerous Is Basal cell carcinoma From INFLIXIMAB?
Of the 1,340 reports, 11 (0.8%) resulted in death, 652 (48.7%) required hospitalization, and 22 (1.6%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 1,340 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
ALENDRONATE (610)
Which INFLIXIMAB Alternatives Have Lower Basal cell carcinoma Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT